Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Board Changes

5 Nov 2018 07:00

RNS Number : 2648G
Cenkos Securities PLC
05 November 2018
 

 

 

 5 November 2018

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Board Changes

The Board is pleased to announce that, subject to FCA approval, Jim Durkin is to be appointed as an Executive Director and to the position of Chief Executive Officer once regulatory approval has been received. In the interim period Anthony Hotson remains as the Company's Chief Executive Officer.

Jim, a founding shareholder of the Company, was formerly Cenkos' Chief Executive Officer in the period December 2011 to July 2017. Jim resigned as Chief Executive Officer in July 2017. Jim Durkin has over 30 years' experience in the UK securities industry. During his career he has had substantial experience originating and executing corporate finance transactions across a range of industries including insurance, property, financials and utilities.

The Board today also announces that Gerry Aherne, the Chairman of the Company has informed the Board that he will step down and retire from the Company with immediate effect.

The Board would like to thank Gerry for his commitment and contribution to the Company as Chairman over the past six years and wish him well in the future.

The Board will commence the search for a new Chairman. Jeff Hewitt a Non-executive Director has been appointed as the acting Chairman in the interim period.

Jeff Hewitt the acting Chairman commented that:

"We welcome Jim back to the Company and have every confidence in Jim in leading the Company going forward. Jim is well placed to undertake the role having previously been on the Board and has been actively involved in the successful management of the Company."

AIM Rules disclosure under Schedule 2(g) of the AIM Rules

James John Durkin (known as Jim Durkin) holds 4,985,831 ordinary shares of 1p each in the Company representing 9.01% of the issued share capital of the Company.

In addition to his appointment to the Board, James John Durkin, aged 58, holds or has held the following directorships or partnerships in the past five years:

Current directorships:

JDPL Limited

 

Previous directorships:

Cenkos Securities plc

Cenkos Nominee UK Limited resigned

Cenkos Fund Management Limited

JDPL 2 Limited

 

There is no further information that is required to be disclosed with regards to the appointment of Jim Durkin pursuant to Schedule 2 paragraph (g) of the AIM Rules.

 

For further information, please contact: 

 

Cenkos Securities plc

Jeff Hewitt, Acting Non- Executive Chairman

 

Tel: 0207 397 8900

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser

 

Tel: 0203 368 3552

Whitman Howard Limited

Nick Lovering, Broker

 

Tel: 0207 659 1224

Buchanan Communications

David Rydell, PR Adviser

 

Tel: 0207 466 5066

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABJBBTMBBMMJP
Date   Source Headline
19th Feb 201810:00 amRNSForm 8.5 (EPT/NON-RI)
15th Feb 201811:26 amRNSEBT Share Purchase
15th Feb 20189:41 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20189:32 amRNSForm 8.5 (EPT/NON-RI)
6th Feb 20185:46 pmRNSHolding(s) in Company
6th Feb 201810:36 amRNSForm 8.5 (EPT/NON-RI)
5th Feb 20189:18 amRNSHolding(s) in Company
31st Jan 20189:37 amRNSFurther re Directorate Change
29th Jan 201810:49 amRNSHolding(s) in Company
29th Jan 201810:48 amRNSHolding(s) in Company
29th Jan 20189:37 amRNSForm 8.5 (EPT/NON-RI)
26th Jan 20181:59 pmRNSDirector/PDMR Shareholding
26th Jan 20187:00 amRNSEBT Share Purchase
25th Jan 20183:35 pmRNSTransaction in Own Shares
24th Jan 201810:31 amRNSForm 8.5 (EPT/NON-RI)
23rd Jan 201810:35 amRNSForm 8.5 (EPT/NON-RI)
22nd Jan 20189:35 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20189:58 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 201810:00 amRNSForm 8.5 (EPT/NON-RI)
17th Jan 20189:28 amRNSForm 8.5 (EPT/NON-RI)
16th Jan 20189:50 amRNSForm 8.5 (EPT/NON-RI)
15th Jan 20189:34 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 201811:11 amRNSForm 8.5 (EPT/NON-RI)
11th Jan 20189:18 amRNSForm 8.5 (EPT/NON-RI)
10th Jan 20189:23 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20189:44 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20189:44 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 20189:49 amRNSForm 8.5 (EPT/NON-RI)
5th Jan 201810:18 amRNSForm 8.5 (EPT/NON-RI)
4th Jan 201810:55 amRNSForm 8.5 (EPT/NON-RI)
3rd Jan 20189:58 amRNSForm 8.5 (EPT/NON-RI)
28th Dec 201710:59 amRNSForm 8.5 (EPT/NON-RI)
27th Dec 201710:55 amRNSForm 8.5 (EPT/NON-RI)
15th Dec 20179:58 amRNSForm 8.5 (EPT/NON-RI)
14th Dec 201710:16 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 201710:13 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 20172:58 pmRNSEBT Share Purchase
8th Dec 20172:30 pmRNSDirector/PDMR Shareholding
8th Dec 201711:48 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 201711:38 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20171:20 pmRNSHolding(s) in Company
24th Nov 20177:00 amRNSDirector/PDMR Shareholding
22nd Nov 20177:00 amRNSDirector/PDMR Shareholding
16th Nov 20179:36 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20171:06 pmRNSDirector/PDMR Shareholding
15th Nov 20179:25 amRNSForm 8.5 (EPT/NON-RI)
13th Nov 20174:03 pmRNSFurther re Directorate Change
9th Nov 201710:44 amRNSForm 8.5 (EPT/NON-RI)
7th Nov 20175:08 pmRNSHolding(s) in Company
7th Nov 201710:25 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.